INVIDIA

News

Artificial Intelligence (AI) healthcare firm Vyasa Analytics has joined a programme designed to nurture start-ups using cutting-edge technology.

News

Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.